ACLS Provider: Course

Incorrect. Lidocaine is an alternative antiarrhythmic for refractory VF, dosed at 1 mg/kg IV/IO.

Incorrect. Immediate CPR is required as asystole is a non-shockable rhythm.

Incorrect. Naloxone is only used in cases of suspected opioid overdose and is not universally administered in cardiac arrest.

Incorrect. Pulse checks should be limited to 5-10 seconds to minimize interruptions in chest compressions.

Incorrect. The initial dose of adenosine for stable SVT in adults is 6 mg IV, followed by 12 mg if needed for subsequent doses.

Incorrect. Atropine is the first-line drug for treating symptomatic bradycardia by increasing heart rate through vagal inhibition.

Incorrect. Placing hands on the lower half of the sternum ensures effective chest compressions without damaging other structures.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for torsades de pointes.

Incorrect. Oxygenation and ventilation should be optimized to avoid hypoxia or hyperoxia during post-cardiac arrest care.

Incorrect. Rhythm checks should be performed every 2 minutes during CPR, coinciding with compressor role switches.

Incorrect. Adenosine is used to terminate stable narrow-complex tachycardia by slowing AV node conduction.

Incorrect. A sudden increase in PETCO2 is a reliable indicator of ROSC, reflecting improved circulation and gas exchange.

Incorrect. Pulse checks should be limited to 10 seconds to minimize interruptions in chest compressions.

Incorrect. Interruptions in chest compressions should be minimized to less than 10 seconds to maintain adequate perfusion.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. Requires immediate defibrillation to restore organized cardiac activity.

Incorrect. Targeted temperature management improves neurological outcomes by preventing further brain injury.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. Epinephrine is repeated every 3-5 minutes during cardiac arrest to enhance perfusion pressure.

Incorrect. A PETCO2 level greater than 10 mmHg indicates that chest compressions are generating adequate blood flow.

Incorrect. A rate of 100-120 compressions per minute optimizes perfusion without compromising cardiac filling.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.

Incorrect. Maximum energy for monophasic defibrillators; for biphasic, follow manufacturer recommendations.

Incorrect. Pulse checks during CPR should not exceed 10 seconds to minimize interruptions in chest compressions.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. Rhythm checks are performed every 2 minutes during pauses in CPR to evaluate for shockable rhythms.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. A 30:2 ratio ensures adequate oxygenation and circulation when no advanced airway is present.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Synchronized cardioversion with 50-100 J is effective for narrow, regular tachycardias that are unstable.

Incorrect. Ventilations are delivered at a rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Two rescuers are needed to maintain high-quality CPR with an advanced airway: one for compressions and one for ventilation.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. Assessing responsiveness is the first step in determining the need for CPR or other interventions in the BLS survey.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. A PETCO2 reading above 10 mmHg indicates that chest compressions are generating sufficient circulation during CPR.

Incorrect. A PETCO2 reading above 10 mmHg indicates adequate chest compressions and cardiac output during CPR.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. High-quality CPR should be resumed immediately after a shock to maintain perfusion and increase the likelihood of ROSC.

Incorrect. TTM is used to reduce neurological injury post-ROSC by maintaining a core temperature of 32-36°C.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Dopamine is used to improve heart rate and contractility in bradycardia unresponsive to atropine.

Incorrect. Optimal for maintaining adequate circulation without risking poor perfusion due to excessive speed.

Incorrect. Naloxone reverses opioid-induced respiratory depression, restoring normal respiratory function.

Incorrect. Atropine is given at 0.5 mg IV every 3-5 minutes for unstable bradycardia caused by vagal stimulation or primary AV block.

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. Epinephrine is given as a continuous infusion to maintain adequate heart rate and perfusion when atropine is ineffective.

Incorrect. The most reliable method to confirm and monitor placement by measuring exhaled CO?.

Incorrect. Defibrillation is the priority for VF and should not be delayed for drug administration, as it is the definitive treatment.

Incorrect. Adenosine is administered as a 6 mg rapid IV push, followed by a saline flush, to terminate reentrant arrhythmias.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. The correct initial dose of amiodarone for pulseless VT is 300 mg IV/IO, followed by 150 mg for a second dose if needed.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.